Loading clinical trials...
Loading clinical trials...
The study protocol is being conducted to compare intermittent high-dose i.v. administation of interferon alpha-2b with the standard high-dose treatment by Kirkwood with distant metastasis free surviva...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Dermatologic Cooperative Oncology Group
NCT07562659 · ctDNA, Colorectal Cancer (CRC), and more
NCT06823440 · CIPN in Adjuvant Breast Cancer Patients
NCT07528066 · Neoadjuvant Chemoimmunotherapy, Robotic Pulmonary Resection, and more
NCT07388771 · NSCLC, Neoadjuvant Therapy
NCT07478900 · Breast Cancer (Locally Advanced or Metastatic), Tattoo Skin Markers, and more
Universitätshautklinik ,St.Josef- Hospital
Bochum
Elbekliniken Buxtehude
Buxtehude
Universitätshautklinik Köln
Cologne
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions